SCHEMBL8611481

SCHEMBL8611481

CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)Oc2ccc(NC(C)=O)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
TDP1 Q9NUW8 2/20 0.58
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
SMN1; SMN2 Q16637 5/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 6/20 0.54
MAPT P10636 3/20 0.54
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA9 Q16790 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
CYP3A4 P08684 2/20 0.53
TSHR P16473 2/20 0.53
CA12 O43570 1/20 0.53
BRD4 O60885 1/20 0.53
NR1I2 O75469 1/20 0.53
MB P02144 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2340576 0.87 MEN1 (0.61) MEN1KMT2ATDP1LMNACYP1A2
SCHEMBL11297176 0.83 KMT2A (0.67) MEN1KMT2ATDP1LMNACYP1A2
SCHEMBL3195794 0.82 RXFP1 (0.54) MEN1KMT2ATDP1LMNACYP1A2
SCHEMBL1403606 0.82 MEN1 (0.56) MEN1KMT2ATDP1LMNACYP1A2
SCHEMBL23098267 0.81 HSD17B10 (0.56) MEN1KMT2ATDP1LMNACYP1A2
SCHEMBL11297174 0.81 MEN1 (0.54) MEN1KMT2ATDP1LMNACYP1A2
SCHEMBL18154532 0.80 TSHR (0.56) CA1CA2CA9NPSR1CYP3A4
SCHEMBL6516221 0.79 KMT2A (0.73) MEN1KMT2ATDP1LMNACYP1A2
SCHEMBL3199696 0.79 RXFP1 (0.50) MEN1KMT2ATDP1LMNASMN1; SMN2
SCHEMBL861674 0.78 SMN1; SMN2 (0.84) MEN1KMT2ATDP1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117136307-A Methods, assays and systems for detecting target analytes 索伦托治疗有限公司 2023-11-28 CN claimed
EP-4278183-A1 METHODS, ASSAYS AND SYSTEMS FOR DETECTION OF A TARGET ANALYTE Sorrento Therapeutics, Inc. (US) 2023-11-22 EP claimed
WO-2022155380-A1 METHODS, ASSAYS AND SYSTEMS FOR DETECTION OF A TARGET ANALYTE VIREX HEALTH, INC. (US) 2022-07-21 WO claimed
EP-0759171-B1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES (GB) 1998-04-15 EP claimed
EP-0759171-A1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES PLC (GB) 1997-02-26 EP claimed
WO-1995031724-A1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES PLC (GB) 1995-11-23 WO claimed
US-4279838-A HYDROLYZING AN N-ACETYLAMINOARYL THIOPHOSPHATE OR PHOSPHATE MITSUI TOATSU CHEMICALS INC. (JP) 1981-07-21 US claimed
US-12607589-B2 Methods, assays and systems for detection of a target analyte SORRENTO THERAPEUTICS, INC. (US) 2026-04-21 US disclosed
US-20240302317-A1 Methods, Assays and Systems for Detection of a Target Analyte SORRENTO THERAPEUTICS, INC. 2024-09-12 US disclosed
CN-117136307-A Methods, assays and systems for detecting target analytes 索伦托治疗有限公司 2023-11-28 CN disclosed
EP-4278183-A1 METHODS, ASSAYS AND SYSTEMS FOR DETECTION OF A TARGET ANALYTE Sorrento Therapeutics, Inc. (US) 2023-11-22 EP disclosed
WO-2022155380-A1 METHODS, ASSAYS AND SYSTEMS FOR DETECTION OF A TARGET ANALYTE VIREX HEALTH, INC. (US) 2022-07-21 WO disclosed
US-10280189-B2 Method for the synthesis of aminoalkylenephosphonic acid MONSANTO TECHNOLOGY LLC (US) 2019-05-07 US disclosed
EP-0759171-B1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES (GB) 1998-04-15 EP disclosed
EP-0759171-A1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES PLC (GB) 1997-02-26 EP disclosed
EP-0759171-A1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES PLC (GB) 1997-02-26 EP disclosed
WO-1995031724-A1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES PLC (GB) 1995-11-23 WO disclosed
WO-1995031724-A1 PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS CAMBRIDGE LIFE SCIENCES PLC (GB) 1995-11-23 WO disclosed
US-4904583-A USING ANALYTE AND TRACER; UNMASKING ENZYME BOUND TO SUPPORTED ANITANALYTE TO UNMASK AND BIND A MASKED ENZYME; SIGNAL ENZYME CONJUGATE. BECTON, DICKINSON AND COMPANY (US) 1990-02-27 US disclosed
US-4279838-A HYDROLYZING AN N-ACETYLAMINOARYL THIOPHOSPHATE OR PHOSPHATE MITSUI TOATSU CHEMICALS INC. (JP) 1981-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12607589-B2 Methods, assays and systems for detection of a target analyte PRSS3, PRSS2, ZP1 MEN1 3062/4885KMT2A 3740/4885TDP1 1212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.